Korea United Pharm Statistics

Total Valuation

Korea United Pharm has a market cap or net worth of KRW 263.48 billion.

Market Cap	263.48B
Enterprise Value	n/a

Important Dates

The last earnings date was Friday, November 29, 2024.

Earnings Date	Nov 29, 2024
Ex-Dividend Date	Dec 27, 2024

Share Statistics

Korea United Pharm has 14.71 million shares outstanding.

Current Share Class	n/a
Shares Outstanding	14.71M
Shares Change (YoY)	n/a
Shares Change (QoQ)	-0.39%
Owned by Insiders (%)	36.02%
Owned by Institutions (%)	4.83%
Float	8.55M

Valuation Ratios

The trailing PE ratio is 14.21.

PE Ratio	14.21
Forward PE	n/a
PS Ratio	1.76
PB Ratio	1.65
P/TBV Ratio	1.58
P/FCF Ratio	23.98
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 3.75, with a Debt / Equity ratio of 0.14.

Current Ratio	3.75
Quick Ratio	2.82
Debt / Equity	0.14
Debt / EBITDA	0.78
Debt / FCF	2.15
Interest Coverage	30.57

Financial Efficiency

Return on equity (ROE) is 12.21% and return on invested capital (ROIC) is 7.82%.

Return on Equity (ROE)	12.21%
Return on Assets (ROA)	6.78%
Return on Capital (ROIC)	7.82%
Revenue Per Employee	242.76M
Profits Per Employee	30.11M
Employee Count	665
Asset Turnover	0.74
Inventory Turnover	2.64

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -24.22% in the last 52 weeks. The beta is 0.33, so Korea United Pharm's price volatility has been lower than the market average.

Beta (5Y)	0.33
52-Week Price Change	-24.22%
50-Day Moving Average	19,642.00
200-Day Moving Average	22,322.00
Relative Strength Index (RSI)	38.54
Average Volume (20 Days)	26,299

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Korea United Pharm had revenue of KRW 161.44 billion and earned 20.02 billion in profits. Earnings per share was 1,260.76.

Revenue	161.44B
Gross Profit	84.80B
Operating Income	23.80B
Pretax Income	25.62B
Net Income	20.02B
EBITDA	30.47B
EBIT	23.80B
Earnings Per Share (EPS)	1,260.76

Full Income Statement

Balance Sheet

The company has 38.20 billion in cash and 23.64 billion in debt, giving a net cash position of 14.56 billion or 989.63 per share.

Cash & Cash Equivalents	38.20B
Total Debt	23.64B
Net Cash	14.56B
Net Cash Per Share	989.63
Equity (Book Value)	170.68B
Book Value Per Share	10,866.83
Working Capital	80.79B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 25.01 billion and capital expenditures -14.02 billion, giving a free cash flow of 10.99 billion.

Operating Cash Flow	25.01B
Capital Expenditures	-14.02B
Free Cash Flow	10.99B
FCF Per Share	746.86

Full Cash Flow Statement

Margins

Gross margin is 52.53%, with operating and profit margins of 14.74% and 12.40%.

Gross Margin	52.53%
Operating Margin	14.74%
Pretax Margin	15.87%
Profit Margin	12.40%
EBITDA Margin	18.88%
EBIT Margin	14.74%
FCF Margin	6.81%

Dividends & Yields

This stock pays an annual dividend of 420.00, which amounts to a dividend yield of 2.35%.

Dividend Per Share	420.00
Dividend Yield	2.35%
Dividend Growth (YoY)	5.00%
Years of Dividend Growth	4
Payout Ratio	15.89%
Buyback Yield	2.69%
Shareholder Yield	5.04%
Earnings Yield	7.04%
FCF Yield	4.17%

Dividend Details

Stock Splits

The last stock split was on January 20, 2014. It was a forward split with a ratio of 1.02.

Last Split Date	Jan 20, 2014
Split Type	Forward
Split Ratio	1.02

Scores

Korea United Pharm has an Altman Z-Score of 5.75.

Altman Z-Score	5.75
Piotroski F-Score	n/a